Trial Profile
Efficacy and safety of olanzapine in patients with borderline personality disorder: a randomised flexible dose double-blind comparison with placebo
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2007
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 25 Jun 2007 Study completed. Results data reported, see 8001077689.
- 15 Jul 2005 New trial record.